Uroxatral and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Uroxatral (alfuzosin hydrochloride) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include death among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Uroxatral and Cipro. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Uroxatral?

Uroxatral has active ingredients of alfuzosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 3,461 Uroxatral users. Check the latest studies of Uroxatral.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Aug, 11, 2026

38 people who take Uroxatral and Cipro together, and have interactions are studied.

Uroxatral and Cipro drug interactions.

What are the common drug interactions of Uroxatral and Cipro, by gender? *:

female:

  1. Death
  2. Dizziness
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Epistaxis (bleed from the nose)
  5. Gait disturbance
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Haemorrhage (bleeding)
  9. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  10. Hypertension (high blood pressure)

male:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Blood glucose increased
  4. Blood pressure increased
  5. Bone disorder
  6. Chronic kidney disease
  7. Drug ineffective
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Heart rate increased
  10. Hypertension (high blood pressure)

What are the common drug interactions of Uroxatral and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Dry mouth

40-49:

n/a

50-59:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Dizziness
  3. Dry mouth
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Epistaxis (bleed from the nose)
  6. Gait disturbance
  7. Haematuria (presence of blood in urine)
  8. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  9. Hypertension (high blood pressure)
  10. Infection parasitic

60+:

  1. Bladder transitional cell carcinoma (types of bladder cancer)
  2. Diarrhoea
  3. Drug ineffective
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Heart rate increased
  6. Muscle spasms (muscle contraction)
  7. Myalgia (muscle pain)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Weight decreased

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 21.05%
  2. Pain: 6 people, 15.79%
  3. Sinusitis (inflammation of sinus): 5 people, 13.16%
  4. Prostatomegaly (enlargement of the prostate): 5 people, 13.16%
  5. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 5 people, 13.16%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 13.16%
  7. Type 2 Diabetes: 4 people, 10.53%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.89%
  9. Metastases To Bone (cancer spreads to bone): 2 people, 5.26%
  10. Heart Attack: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Uroxatral and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Uroxatral and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Uroxatral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uroxatral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alfuzosin hydrochloride and ciprofloxacin hydrochloride (the active ingredients of Uroxatral and Cipro, respectively), and Uroxatral and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: